Trial Balance Trust Receipt as of November 30, 2020
Trial Balance Regular Agency Fund as of November 30, 2020
Trial Balance Internally Generated Income as of October 31, 2020
Trial Balance Internally Generated Income as of November 30, 2020
Trial Balance Trust Receipt as of October 31, 2020
Trial Balance Business Type Income as of October 31, 2020
Statement of Changes in Net Assets/Equity Regular Agency Fund as of December 31, 2020
Statement of Cash Flows Consolidated-All Funds for the year ended December 31, 2020
Pre-Closing Trial Balance Regular Agency Fund as of December 31, 2020
Pre-Closing Trial Balance Internally Generated Income as of December 31, 2020
Statement of Changes in Net Assets /Equity Business Type Income As of December 31, 2020
Statement of Cash Flows Consolidated-All Funds for the Year ended December 31, 2019 and 2020
Post-Closing Trial Balance Internally Generated Income as of December 31, 2020
Pre-Closing Trial Balance Business Type Income as of December 31, 2020
Notes to Financial Statements for the Year ended December 31, 2020
FY 2021 Monthly Disbursement Program (In thousand pesos)
FY 2021 Monthly Disbursement Program (In thousand pesos)
FY 2021 Financial Plan (in thousand pesos)
Post-Closing Trial Balance Trust Receipt as of December 31, 2020
Detailed Statement of Financial Position Regular Agency Fund as of December 31, 2020
Detailed Statement of Financial Position Internally Generated Income as of December 31, 2021
Detailed Statement of Financial Position Consolidated-All Funds as of December 31, 2020
Detailed Statement of Financial Position Business Type Income as of December 31, 2020
Detailed Statement of Financial Performance Trust Receipt for the period ending December 31, 2020
Detailed Statement of Financial Performance December 31, 2019 and 2020 (2)
Detailed Statement of Financial Performance December 31, 2019 and 2020
Detailed Statement of Financial Performance December 31, 2019 and December 31, 2020
Detailed Statement of Cash Flows Trust Receipt for the Period January 01, 2020 to December 31, 2020
Detailed Statement of Cash Flows Business Type Income December 31, 2020
Condensed Statement of Financial Position Trust Receipt as of December 31, 2020
Condensed Statement of Financial Position Business Type Income
Condensed Statement of Financial Performance Trust Receipt for the period ending December 31, 2020
Condensed Statement of Cash Flows Trust Receipt for the period January 01, 2020 to December 31, 2020
Condensed Statement of Cash Flows Trust Receipt December 31, 2020
Condensed Statement of Cash Flows Regular Agency Fund December 31, 2020
Condensed Statement of Cash Flows Internally Generated Income December 31, 2020
Condensed Statement of Cash Flows Business Type Income December 31, 2020
Trial Balance Trust Receipt as of August 31, 2020
Trial Balance Regular Agency Fund as of August 31, 2020
Trial Balance Internally Generated Income as of August 31, 2020
Trial Balance Business Type Income as of August 31, 2020
List of Allotments and Sub-Allotments as at the Quarter Ending June 30, 2020
Trial Balance Trust Receipt as of July 31, 2020
Trial Balance Regular Agency Fund as of July 31, 2020
Trial Balance Internally Generated Income as of July 31, 2020
Trial Balance Business Type Income as of July 31, 2020
Condensed Statement of Cash Flows Regular Agency Fund for the Period June 01, 2020 to June 30, 2020
Condensed Statement of Cash Flows Trust Receipt for the Period June 01, 2020 to June 30, 2020
Condensed Statement of Financial Performance Regular Agency Fund for the period Ending June 30, 2020
Condensed Statement of Financial Performance Trust Receipt for the Period ending June 30, 2020
Condensed Statement of Financial Position Internally Generated Income as of June 30, 2020
Condensed Statement of Financial Position Regular Agency Fund as of June 30, 2020
Condensed Statement of Financial Position Trust Receipt as of June 30, 2020
Detailed Statement of Cash Flows Regular Agency Fund For the Period June 01, 2020 to June 30, 2020
Detailed Statement of Cash Flows Trust Receipt for the Period June 01, 2020 to June 30, 2020
Detailed Statement of Financial Performance Regular Agency Fund for the Period Ending June 30, 2020
Detailed Statement of Financial Performance Trust Receipt for the Period Ending June 30, 2020
Detailed Statement of Financial Position Internally Generated Income as of June 30, 2020
Detailed Statement of Financial Position Regular Agency Fund as of June 30, 2020
Detailed Statement of Financial Position Trust Receipt as of June 30, 2020
Statement of Changes in Net Assets/Equity Internally Generated Income as of June 30, 2020
Statement of Changes in Net Assets/Equity Trust Receipt as of June 30, 2020
Statement of Changes in Net Assets/Equity Regular Agency Fund as of June 30, 2020
Trial Balance Business Type Income as of June 30, 2020
Trial Balance Internally Generated Income as of June 30, 2020
Trial Balance Regular Agency Fund as of June 30, 2020
Trial Balance Trust Receipt as of June 30, 2020
Trial Balance Trust Receipt as of May 31, 2020
Trial Balance Regular Agency Fund as of May 31, 2020
Trial Balance Internally Generated Income as of May 31, 2020
Trial Balance Business Type Income as of May 31, 2020
Trial Balance Trust Receipt as of April 30, 2020
Trial Balance Business Type Income as of April 30, 2020
Trial Balance Regular Agency Fund as of April 30, 2020
Trial Balance Internally Generated Income as of April 30, 2020
Trial Balance Trust Receipt as of March 31, 2020
Trial Balance Regular Agency Fund as of March 31, 2020
Trial Balance Internally Generated Income as of March 31, 2020
Trial Balance Business Type Income as of March 31, 2020
Statement of Changes in Net Assets/Equity Trust Receipt as of March 31, 2020
Statement of Changes in Net Assets/Equity Business Type Income as of March 31, 2020
Statement of Changes in Net Assets/Equity Regular Agency Fund as of March 31, 2020
Statement of Changes in Net Assets/Equity Internally Generated Income as of March 31, 2020
Detailed Statement of Financial Position Trust Receipt as of March 31, 2020
Detailed Statement of Financial Position Regular Agency Fund as of March 31, 2020
Detailed Statement of Financial Position Internally Generated Income As of March 31, 2020
Detailed Statement of Financial Position Business Type Income as of March 31, 2020
Detailed Statement of Financial Performance Trust Receipt for the Period ending March 31, 2020
Detailed Statement of Cash Flows For the Period Jan 1 to March 31, 2020
Condensed Statement of Financial Position Trust Receipt as of March 31, 2020
Condensed Statement of Financial Position Regular Agency Fund as of March 31, 2020
Condensed Statement of Financial Position Internally Generated Income as of March 31, 2020
Condensed Statement of Financial Position Internally Generated Income
Condensed Statement of Financial Position Business Type Income as of March 31, 2020
Condensed Statement of Financial Performance Trust Receipt For the Period ending March 31, 2020
Condensed Statement of Cash Flows for the Period Jan. 1 to March 31, 2020
List of Allotments and Sub-Allotments as of the Quarter Ending March 31, 2020